Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026Medtronic (NYSE: MDT) and Orchestra BioMed intend to pursue late-breaking ...

Cabaletta Bio (CABA) remains a Buy: rese-cel trial catalysts, autoimmune upside, scalable manufacturing, and key risks like ...

Medical imaging routinely used in cancer care may hold far more biological information than previously thought.

Scholar Rock Holding Corporation ( SRRK) Q1 2026 Earnings Call May 7, 2026 8:00 AM EDT Good morning, ladies and gentlemen, and welcome to Scholar Rock's First Quarter 2026 Conference Call. [Operator ...

United Therapeutics Corporation (NASDAQ: UTHR) Q1 2026 Earnings Call Transcript May 6, 2026 United Therapeutics Corporation ...

Colloquially, OCD is known as the doubting disorder. In his new book “How to Not Know,” Simone Stolzoff explores whether ...

Medical imaging routinely used in cancer care may hold far more biological information than previously thought. An international study involving Umeå ...

Data from Phase 1b/2 trial of evorpacept + zanidatamab presented at ESMO Breast Cancer 2026 showed all patients with confirmed HER2-positive ...

TAGMO Clinical Readouts -- Initial results for head and neck, and upper GI adenocarcinoma cohorts are expected midyear, with ...

For decades, parasite control in cattle has followed a familiar script: Treat the whole herd in the spring, treat again in ...

Beyond chronic diseases, CNS drug delivery is also a critical factor in biodefense and national security. As traditional drug-delivery approaches continue to face limitations, alternative methods ...

Progression-Free Survival (PFS): The length of time during and after treatment that a patient lives with disease but without it worsening, a key efficacy endpoint in oncology studies.